In insulin-resistant rats, SM (100 mg/kg/day) was indicated to inhibit the AlCl3-induced activation of the TLR4 signalling pathway, including the downstream induction of NF-κB [223]. This evidence concerns the gene NFKB1 and Insulin resistance.